开发微生物生物标志物,用于检测和预测早期非小细胞肺癌
Fares Darawshy1,2,3, Jun-Chieh J Tsay1,4,5, Leopoldo N Segal1,4,6
1Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
Cancer biomarkers : section A of Disease markers
|April 30, 2025
概括
肺微生物组可能有助于早期发现非小细胞肺癌 (NSCLC). 微生物签名显示为NSCLC诊断和管理的生物标志物有前途,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 生物标志物发现发现
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
- 目前用于NSCLC的生物标志物缺乏足够的敏感性和特异性用于临床使用.
- 下呼吸道微生物组越来越多地被认为在NSCLC中的作用.
研究的目的:
- 审查局部和全身微生物组在早期NSCLC中的作用.
- 探索基于微生物组的生物标志物的潜力,用于NSCLC诊断和风险分层.
- 讨论NSCLC微生物组生物标志物研究的挑战和未来方向.
主要方法:
- 关于肺微生物组和NSCLC的最近研究的文献综述.
- 分析与NSCLC发育和进展相关的已识别的微生物种群.
- 讨论将微生物组数据与其他"omics"平台集成.
主要成果:
- 特定的微生物特征与NSCLC的发展,进展和预后有关.
- 肺部微生物组为NSCLC的发病过程提供了潜在的见解.
- 组合的"omics"方法可能会产生更全面的生物标志物签名.
结论:
- 基于微生物组的生物标志物对早期NSCLC检测和风险分层有希望.
- 需要进一步的研究来克服样本处理,测序和数据分析方面的挑战.
- 微生物组研究可能会对NSCLC早期检测和管理策略产生重大影响.
更多相关视频
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.5K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
981
相关概念视频
Microbial Biosensors
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
